Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

ACADIA Pharmaceuticals Inc (ACAD)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow ACADIA's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
17.08 +0.03    +0.18%
02/05 - Closed. Currency in USD ( Disclaimer )
After Hours
16.97
-0.11
-0.64%
18:36:59 - Real-time Data
  • Volume: 1,286,569
  • Bid/Ask: 16.95 / 17.50
  • Day's Range: 16.81 - 17.38
Type:  Equity
Market:  United States
ACADIA 17.08 +0.03 +0.18%

ACAD Income Statement

 
Featured here, the Income Statement (earnings report) for ACADIA Pharmaceuticals Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Revenue 231.04 211.7 165.24 118.46
Revenue 231.04 211.7 165.24 118.46
Other Revenue, Total - - - -
Cost of Revenue, Total 84.63 171.58 66.23 70.81
Gross Profit 146.41 40.11 99 47.65
Total Operating Expenses 196.1 269.48 162.2 172.05
Selling/General/Admin. Expenses, Total 111.46 97.89 95.97 101.24
Research & Development 66.74 156.96 58.77 69.14
Depreciation / Amortization -1.23 0.359 0.402 0.426
Interest Expense (Income) - Net Operating - - - -
Unusual Expense (Income) - - - -
Other Operating Expenses, Total -65.51 -157.32 -59.17 -69.57
Operating Income 34.94 -57.78 3.04 -53.58
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets 5.11 - - -
Other, Net -9.87 -5.63 -3.31 -8.64
Net Income Before Taxes 39.7 -52.14 6.34 -44.94
Provision for Income Taxes -6.09 13.03 5.23 -1.92
Net Income After Taxes 45.8 -65.18 1.11 -43.02
Minority Interest - - - -
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 45.8 -65.18 1.11 -43.02
Total Extraordinary Items - - - -
Net Income 45.8 -65.18 1.11 -43.02
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 45.8 -65.18 1.11 -43.02
Dilution Adjustment -0.673 - -0.536 -
Diluted Net Income 46.47 -65.18 1.65 -43.02
Diluted Weighted Average Shares 166.51 164.23 165.05 162.26
Diluted EPS Excluding Extraordinary Items 0.278 -0.397 0.007 -0.265
DPS - Common Stock Primary Issue - - - -
Diluted Normalized EPS 0.13 -0.198 0.024 -0.173
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ACAD Comments

Write your thoughts about ACADIA Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Game Insighter
Game Insighter Apr 07, 2021 10:04
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy
Pouyan Pourjam
Pouyan Pourjam Apr 07, 2021 10:04
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why? Potentia growth ?
Game Insighter
Game Insighter Apr 06, 2021 13:22
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what to do?
umair khattak
umair khattak Sep 20, 2018 13:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
the stock has been beaten up very badly due to the concerns in the past few months. now that the fda has made it clear, it is a very strong buy on the hourly and weekly.
Ankit Choudhary
Ankit Choudhary Sep 20, 2018 13:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
yeah i saw the news vaccine of this company got selected for expansion
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email